Shares of AstraZeneca (NASDAQ:AZN) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved down to $57.99.
FibroGen, Inc. (NASDAQ: FGEN) has a key catalyst Thursday when FDA's Cardiovascular and Renal Drugs Advisory Committee will issue its recommendation on the company's new drug application for roxadustat.
The committee is scheduled to meet between 9:30 a.m. and 5:30 p.m.
The FDA on Friday approved Bayer AG’s (OTC:BAYRY) chronic kidney disease (CKD) drug Kerendia (finerenone), the first and only nonsteroidal mineralocorticoid…
The cover story in this weekend's Barron's reveals what investors should know now about the so-called meme stocks.
Other featured articles discuss how to find bargains in Chinese stocks, the increasing likelihood of big tech regulation and how travel and leisure stocks have fared lately.
1Hon Hai Precision Industry Co., Ltd. (OTC: HNHAF), popularly known as Foxconn, and Taiwan Semiconductor Manufacturing Company (NYSE: TSM) are joining hands for a purpose unrelated to their core businesses.
European Medicines Agency (EMA) has established a probable link between heart inflammation and mRNA-based COVID-19 vaccines made by Pfizer Inc (NYSE:PFE) and Moderna…